01 8Aptiom
02 5Zebinix
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 63
2019 Revenue in Millions : 58
Growth (%) : 8
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 253
2019 Revenue in Millions : 212
Growth (%) : 19
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 225
2020 Revenue in Millions : 253
Growth (%) : 2
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 49
2020 Revenue in Millions : 60
Growth (%) : -12
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 249
2021 Revenue in Millions : 225
Growth (%) : 11
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 227
2022 Revenue in Millions : 249
Growth (%) : 3
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 92
2015 Revenue in Millions : 57
Growth (%) : 62
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 278
2016 Revenue in Millions : 199
Growth (%) : 40
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 178
2017 Revenue in Millions : 141
Growth (%) : 26%
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 49
2016 Revenue in Millions : 35
Growth (%) : 42
LOOKING FOR A SUPPLIER?